First in Man Evaluation of the Safety and Potential Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection

被引：0
|
作者：
Flechner, S. M. [1 ]
Mulgaonkar, S. [2 ]
Melton, L. [3 ]
Wiseman, A. [4 ]
Sung, R. [5 ]
Waid, T. [6 ]
Shihab, F. [7 ]
Agarwal, A. [8 ]
Getts, Tegaue M. [9 ]
Getts, D. R. [9 ,10 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] St Barnabas Hosp, Livingston, NJ USA
[3] Baylor Univ, Med Ctr, Dallas, TX USA
[4] Univ Colorado, Denver, CO 80202 USA
[5] Univ Michigan, Ann Arbor, MI 48109 USA
[6] Univ Kentucky, Lexington, KY USA
[7] Univ Utah, Salt Lak City, UT USA
[8] Univ Virginia, Charlottesville, VA USA
[9] Tolera Therapeut Inc, Kalamazoo, MI USA
[10] Northwestern Univ, Chicago, IL 60611 USA
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-00188
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
434
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [21] Low dose thymoglobulin versus Simulect induction in adult kidney transplant with CNI triple immunosuppression: Efficacy and safety
    Laftavi, Mark Reza
    Sharma, Satish
    Kohli, Romesh
    Tullock, Jamey
    Dayton, Merril
    Danek, Melissa
    Pankewycz, Oleh
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 440 - 440
  • [22] EFFICACY AND SAFETY OF OUTPATIENT RABBIT-ANTITHYMOCYTE GLOBULIN INDUCTION IN DE-NOVO KIDNEY TRANSPLANT RECIPIENTS
    Sparkes, Tracy M.
    Trofe-Clark, Jennifer
    Reese, Peter P.
    Jakobowski, Diane
    Goral, Simin
    Doll, Stacey L.
    Abt, Peter L.
    Sawinski, Deirdre
    MBloom, Roy D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 509 - 510
  • [23] Intravenous Immunoglobulins Failed to Prevent Acute Antibody-Mediated Rejection in Kidney Transplant Recipients with De Novo DSA within the First Year After Transplant
    Matignon, M.
    Pilon, C.
    Commereuc, M.
    Grondin, C.
    Kofman, T.
    Lang, P.
    Poitrine, F. Canoui
    Cohen, J.
    Grimbert, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 437 - 438
  • [24] Microrna expression changes in kidney transplant: Diagnostic efficacy of MIR-150-5P as potential rejection biomarker
    Alfaro, Rafael
    Legaz, Isabel
    Jimenez-Coll, Victor
    Martinez-Banaclocha, Helios
    Antonio Galian, Jose
    Botella, Carmen
    Rosa Moya-Quiles, Maria
    Minguela, Alfredo
    Llorente, Santiago
    Muro, Manuel
    HLA, 2022, 99 (05) : 465 - 465
  • [25] Efficacy and safety of Daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression
    Ciancio, G
    Burke, GW
    Suzart, K
    Vaidya, A
    Roth, D
    Kupin, W
    Mattiazzi, A
    Rosen, A
    Esquenazi, V
    Miller, J
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) : 873 - 874
  • [26] Low-Dose Rabbit Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients at High Immunologic Risk is Safe and May Prevent Excess Rejection
    Sartain, E.
    Nettles, B.
    Crowther, B.
    Klem, P.
    Schwarz, K.
    Davis, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 903 - 903
  • [27] Evaluation of the Safety and Efficacy of Valganciclovir to Prevent Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients Utilizing Two Dosing Regimens
    Le, K.
    Patel, A.
    Jasiak-Panek, N. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 379 - 379
  • [28] MicroRNA Expression Changes in Kidney Transplant: Diagnostic Efficacy of miR-150-5p as Potential Rejection Biomarker, Pilot Study
    Alfaro, Rafael
    Legaz, Isabel
    Jimenez-Coll, Victor
    El Kaaoui El Band, Jaouad
    Martinez-Banaclocha, Helios
    Galian, Jose Antonio
    Parrado, Antonio
    Mrowiec, Anna
    Botella, Carmen
    Moya-Quiles, Maria Rosa
    Boix, Francisco
    de la Pena-moral, Jesus
    Minguela, Alfredo
    Llorente, Santiago
    Muro, Manuel
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (13)
  • [29] Efficacy and Safety of Perioperative Angiotensin II Versus Phenylephrine as a First-Line Continuous Infusion Vasopressor in Kidney Transplant Recipients
    Beltran, Lyra P.
    Benken, Jamie
    Jou, Jonathan
    Benedetti, Enrico
    Nishioka, Hokuto
    Alamreia, Enas
    Belcher, Rachel M.
    Benken, Scott T.
    CLINICAL TRANSPLANTATION, 2024, 38 (08)
  • [30] Induction immunosuppression in kidney transplant recipients older than 60 years of age -: Safety and efficacy of ATGAM®, OKT3® and Simulect®
    Heifets, M
    Saeed, MI
    Parikh, MH
    Sierka, D
    Kumar, MSA
    DRUGS & AGING, 2004, 21 (11) : 747 - 756
12345